Questionnaire for the Evaluation of Anger, Hostility and Aggression After Acquired Brain Injury.

Overview

The incidence of aggression and violent behavior is usually reported to be high after acquired brain injury, around 54%. Behaviors with verbal agression and, less frequently, physical agressions, are described. These behaviors may be linked to the dysfunction of the frontal lobes responsible for executive functions and complex social interactions, or to the dysfunction of the temporal structures that may also be responsible for increased aggression. It is interesting to note that very few scales or specific questionnaires evaluate the factors and co-variables that could lead to aggressive behavior after an acquired brain injury. Such questionnaires are very rare, and none have been validated in French. The objective of this study is to develop a questionnaire in French that aims to assess anger, hostility and aggression after acquired brain injury. The psychometric qualities of this questionnaire will be evaluated using the Rasch probabilistic model. The development of such a tool will be of major interest for clinical practice and future clinical research.

Full Title of Study: “SOCIALBI, a Rasch Questionnaire for the Evaluation of Anger, Hostility and Aggression After Acquired Brain Injury.”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Diagnostic
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 2021

Interventions

  • Other: Questionnaire
    • questionnaire

Arms, Groups and Cohorts

  • Experimental: Patients with acquired brain injury

Clinical Trial Outcome Measures

Primary Measures

  • Questionnaire evaluation by Rasch methodology
    • Time Frame: 30 minutes
    • questionnaire validity

Participating in This Clinical Trial

Inclusion Criteria

  • Patients of the CHU Brugmann Hospital – Central neurological pathology of vascular or traumatic origin, acute or chronic (known since more than one year). Exclusion Criteria:

  • Pregnant or lactating women – Presence or antecedents of psychiatric disease – Degenerative pathology (ex: Parkinson…) – Antecedents of other neurologic pathologies before the acquired lesion – Oral or written comprehension dysfunctions.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 75 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Eric Durand
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Eric Durand, Head of clinic (Physical medicine) – Brugmann University Hospital
  • Overall Official(s)
    • Eric Durand, MD, Principal Investigator, CHU Brugmann
  • Overall Contact(s)
    • Eric Durand, MD, 3224758121, Eric.DURAND@chu-brugmann.be

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.